Influence of Biological Parameters Assessed in [18F]FDG PET/CT on Overall Survival in Cervical Cancer Patients

被引:12
作者
Cegla, Paulina [1 ]
Burchardt, Ewa [2 ]
Roszak, Andrzej [2 ,3 ]
Czepczynski, Rafal [4 ]
Kubiak, Anna [5 ]
Cholewinski, Witold [1 ,3 ]
机构
[1] Med Univ Poznan, Greater Poland Canc Ctr, Dept Nucl Med, Poznan, Poland
[2] Med Univ Poznan, Greater Poland Canc Ctr, Dept Radiotherapy & Gynaecol Oncol, Poznan, Poland
[3] Med Univ Poznan, Chair & Dept Electroradiol, Poznan, Poland
[4] Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland
[5] Greater Poland Canc Ctr, Greater Poland Canc Registry, Poznan, Poland
关键词
cervical cancer; oncology; PET; CT;
D O I
10.1097/RLU.0000000000002733
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim The aim of this study was to estimate the influence of biological parameters assessed in [F-18]FDG PET/CT on overall survival (OS) in cervical cancer patients. Methods Retrospective analysis was performed on a group of 371 patients with newly diagnosed and histologically confirmed cervical cancer. PET biological parameters in primary tumor including SUVmax, SUVmean, total lesion glycolysis (TLG), metabolic tumor volume (MTV), heterogeneity, and parameters referring both to primary tumor and metastatic lesions: SUVtotal, TLG(total), and MTVtotal, were analyzed. Results Based on PET/CT results, 3 subgroups were identified: cervical only-with disease limited only to the cervix (38%), +regional nodes-where increased glucose accumulation in addition to the cervical area was also observed in regional lymph nodes (36%), and +distal metastases-where PET scan showed a disseminated disease (26%). Depending on the stage of the disease, in the cervical-only group, 5-year survival rate was 86%; in the +regional nodes group, it was 80%; whereas in the +distal metastases group, 5-year survival rate was only 55%. However, based on Cox regression model, significant influence on OS was found only in heterogeneity of primary tumor; more inhomogeneous tumors suggest worse prognosis (0.25 +/- 0.04 vs 0.16 +/- 0.09, P < 0.001), SUVtotal (76.6 +/- 130.1 vs 45.4 +/- 73.4, P = 0.002), and MTVtotal (79.03 +/- 88.27 vs 63.00 +/- 83.80 cm(3), P = 0.03). For heterogeneity, cutoff point suggesting worse prognosis was 0.18; for SUVtotal, 52.3; and for MTVtotal, 66.55 cm(3). Conclusions Stage of disease assessed in [F-18]FDG PET/CT significantly influences survival rate in patients with cervical cancer. SUVtotal, MTVtotal, and heterogeneity of primary tumor are independent prognostic factors on OS in cervical cancer patients.
引用
收藏
页码:860 / 863
页数:4
相关论文
共 13 条
[1]  
[Anonymous], SURV EP END RES
[2]   Pitfalls and Pearls of Wisdom in F-18-FDG PET Imaging of Tumors [J].
Britton, Tracey ;
Robinson, Nicholas .
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2016, 44 (02) :59-64
[3]   Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer [J].
Chung, Hyun Hoon ;
Kang, Seo Young ;
Ha, Seunggyun ;
Kim, Jae-Weon ;
Park, Noh-Hyun ;
Song, Yong Sang ;
Cheon, Gi Jeong .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (02)
[4]   Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 [J].
Ferlay, J. ;
Steliarova-Foucher, E. ;
Lortet-Tieulent, J. ;
Rosso, S. ;
Coebergh, J. W. W. ;
Comber, H. ;
Forman, D. ;
Bray, F. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1374-1403
[5]  
Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
[6]   18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers? [J].
Kendi, A. T. ;
Corey, A. ;
Magliocca, K. R. ;
Nickleach, D. C. ;
Galt, J. ;
Switchenko, J. M. ;
El-Deiry, M. W. ;
Wadsworth, J. T. ;
Hudgins, P. A. ;
Saba, N. F. ;
Schuster, D. M. .
EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (06) :1171-1176
[7]   The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival [J].
Kidd, Elizabeth A. ;
Siegel, Barry A. ;
Dehdashti, Farrokh ;
Grigsby, Perry W. .
CANCER, 2007, 110 (08) :1738-1744
[8]   Cervical Cancer Histology and Tumor Differentiation Affect 18F-Fluorodeoxyglucose Uptake [J].
Kidd, Elizabeth A. ;
Spencer, Christopher R. ;
Huettner, Phyllis C. ;
Siegel, Barry A. ;
Dehdashti, Farrokh ;
Rader, Janet S. ;
Grigsby, Perry W. .
CANCER, 2009, 115 (15) :3548-3554
[9]   Advances in diagnosis and treatment of metastatic cervical cancer [J].
Li, Haoran ;
Wu, Xiaohua ;
Cheng, Xi .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (04)
[10]   The Role of PET/CT in the Management of Cervical Cancer [J].
Mirpour, Sahar ;
Mhlanga, Joyce C. ;
Logeswaran, Prashanti ;
Russo, Gregory ;
Mercier, Gustavo ;
Subramaniam, Rathan M. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 201 (02) :W192-W205